Potential role of the PD-L1 expression and tumor-infiltrating lymphocytes on neuroblastoma.

Shogo ZuoMasayuki ShoToshio SawaiHiromichi KanehiroKosaku MaedaMakiko YoshidaRyo TsukadaMotonari NomuraHiroomi Okuyama

Published in: Pediatric surgery international (2020)

Our findings suggest that the PD-L1 tumor expression might be a good biomarker for the treatment of neuroblastoma patients, especially for advanced neuroblastoma.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
poor prognosis
peritoneal dialysis
patient reported outcomes
binding protein
long non coding rna